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To the Editor: 
Schaefer et al.1 (referred to as Study_1) recently presented the provocative 
conclusion that CRISPR-Cas9 nuclease can induce many unexpected off-target 
mutations across the genome that arise from the sites with poor homology to the gRNA. 
As Wilson et al.2 pointed out, however, the selection of a co-housed mouse as the 
control is insufficient to attribute the observed mutation differences between the 
CRISPR-treated mice and control mice. Therefore, the causes of these mutations need 
to be further investigated. In 2015, Iyer et al.3 (referred to as Study_2) used Cas9 and 
a pair of sgRNAs to mutate the Ar gene in vivo and off-target mutations were 
investigated by comparison the control mice and the offspring of the modified mice. 
After analyzing the whole genome sequencing (WGS) of the offspring and the control 
mice, they claimed that off-target mutations are rare from CRISPR-Cas9 engineering. 
Notably, their study only focused on indel off-target mutations. We re-analyzed the 
WGS data of these two studies and detected both single nucleotide variants (SNVs) and 
indel mutations. 
 
Because these two studies draw relatively opposite conclusions on the off-targeting 
of the CRISPR system on the whole genome, the origins or causes of the mutations 
need to be cautiously examined. Here we performed a computationally evolutionary 
investigation (Figure 1a) to re-analyze the WGS data of these two studies with a direct 
comparison of the experiment design and analysis results (Table 1 and Supplementary 
Table 1). The computational framework designed for the above analysis can accurately 
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infer the likelihood of the origins of these mutations, i.e., whether these mutations are 
germline-like or not. This controversial issue arises substantially arguments but is 
unresolved1-4. Here our analysis concluded that the so-called unexpected SNVs pattern 
(Supplementary Notes and Figure 1a) in Study_1 are not typically germline-like, 
while for Study_2, the detected SNVs are in fact germline mutations. 
  
 Thousands of genomic mutations were found from both studies based on our 
computational framework (Supplementary Table 2). Following our strict criteria to 
filter SNVs with low mutation frequency and indels overlapping with the UCSC 
Genome Browser5,6 short tandem repeat, we confirmed a low number of so-called 
unexpected mutations claimed in Study_11(Supplementary Table 2). A great deal of 
filtered mutations are potentially false positives arising from spontaneous mutations, 
sequencing and Burrows-Wheeler Aligner(BWA)7 alignment errors. This leads us 
believe that the calling of CRISPR-induced mutations especially indels should be 
carefully performed to avoid false positives. We integrated two computational methods 
to infer the putative origins of these detected SNVs, by (1) quantitatively analyzing the 
similarity of the mutation pattern8-11 (Supplementary Table 3) between the reference 
germline SNVs (derived from well-curated public databases5,9; Figure 1a and 
Supplementary Notes) and the detected SNVs derived from Study_1 and Study_2 
followed our re-analysis pipeline. The rationale is that for a particular organism (e.g., 
mouse), its germline mutation pattern should be evolutionarily conserved; (2) we 
applied a hypergeometric distribution to test the difference of mutation heterozygosity 
between the sample-level germline SNVs (detected using GATK HaplotypeCaller; 
Figure 1a and Supplementary Notes) and the detected SNVs. 
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 Figure 1 (a) Overview of our computational framework to re-analyze the WGS data of these two studies. (b) 
Heatmap of the similarities of the mutation pattern between the reference germline SNVs and the detected 
SNVs. (c) The detected SNVs mutation frequency in these two studies. (F03 and F05 are the samples from 
Study_1, F03_F05 SNVs is the intersection SNVs of these two samples. F18_9, F18_12，F25_4, F25_5 and 
F25_6 are the samples from Study_2). (d) Heterozygosity of the detected SNVs and the sample-level germline 
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SNVs. 
 
 As seen in the heatmap (Figure 1b), the detected SNV mutation pattern correctly 
cluster the samples from different studies. In addition, the mutation pattern of samples 
from Study_2 highly correlated with the reference dbSNP germline mutation pattern 
(R2~0.85, P-value <2.2e-16), while the correlation between the samples from Study_1 
and the reference dbSNP germline was weaker (R2~0.55, P-value~1e-10). Although the 
correlation of mutation pattern in either study with germline at evolution scale are 
relatively low, we found that the samples from Study_2 correlated stronger with 
germline mutation pattern than those of samples from Study_1. 
 
 The heterozygosity of the so-called unexpected SNVs of the samples in Study_1 
was 67.2% and 70.4%, respectively (Figure 1c), while that of the sample-level 
germline SNVs was much lower (Figure 1c). We reasoned that if all the detected SNVs 
were germline, the heterozygosity of such SNVs would be nearly identical to that of 
the sample-level germline SNVs. Our statistical test, however, indicates a significant 
difference between the heterozygosity of them (p-value=0; Supplementary Notes), 
proving that the overall derived mutation pattern in Study_1 is not germline-like. Note 
that Lareau et al. and Kim et al.4,6 recently demonstrated that the two CRISPR-Cas9 
treated mice (F03, F05) in Study_1 are actually more closely related to each other 
genetically than to the control mouse, proving that these mutations are most likely pre-
existing variants. Our analysis result further presented that there are unusual SNVs 
arose in Study_1 combined with pre-existing variants, and the overall mutation pattern 
in vivo are not germline-like. In contrast, in Study_2, we cannot reject the null 
hypothesis that the detected SNVs were sampled from the germline background. We 
computationally validated that the majority of the detected mutations in Study_2 are 
germline, which is consistent with their original notation that off-target somatic 
mutations are rare in their Cas9-modified mice3.  
 
 Because the same CRISPR genome-editing technology led to different conclusions 
in two studies, we performed a direct comparison of these two studies to evaluate the 
possible causes for the differences (Table 1 and Supplementary Table 1). First, the 
experimental protocols differ, where the protocol used in Study_1 is not a routine and 
well-accepted CRISPR knockout protocol (sgRNA plasmid + Cas9 protein). The 
potentiality to induce unusual mutation patterns with such protocol are waiting to be 
further explored. Secondly, the whole genome sequencing of the founder mouse should 
be performed before CRISPR knockout. The founder genetic variation should be 
carefully examined in both studies, since such genetic variation, which may contain in 
the zygotes, can confound the target sites of certain sgRNAs more than others. This 
information should be integrated into the study for sgRNA selection to ensure safety12.  
 
 In summary, we demonstrated that the unexpected CRISPR off-target mutation 
pattern in Study_1 are not typically germline-like. Some of unusual and unidentified 
mutations may arise in Study_1, but the real reasons remain to be explored. Based on 
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the available data and a direct comparison of the two studies, we presented two possible 
reasons and future re-analysis directions that may contribute to such different 
conclusions. To characterize the authentic CRISPR-mediated mutations, we are 
required to have appropriate controls to rule out other sources of mutations, which will 
be needed for benchmarking of targeting safety of CRISPR-based gene therapy.    
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